Guizhou Xinbang Pharmaceutical Co (SZSE:002390) Growth Rank : 4 (As of Apr. 30, 2025)

View and export this data going back to 2010. Start your Free Trial

What is Guizhou Xinbang Pharmaceutical Co Growth Rank?

Guizhou Xinbang Pharmaceutical Co has the Growth Rank of 4.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability, rated on a scale from 1 to 10. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

A higher score reflects a greater ability to drive business growth, with companies considered to have strong and sustainable expansion potential. Conversely, a lower score indicates challenges in achieving consistent growth and scalability.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

Competitive Comparison of Guizhou Xinbang Pharmaceutical Co's Growth Rank

For the Drug Manufacturers - Specialty & Generic subindustry, Guizhou Xinbang Pharmaceutical Co's Growth Rank, along with its competitors' market caps and Growth Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Guizhou Xinbang Pharmaceutical Co's Growth Rank Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Guizhou Xinbang Pharmaceutical Co's Growth Rank distribution charts can be found below:

* The bar in red indicates where Guizhou Xinbang Pharmaceutical Co's Growth Rank falls into.

Save Embed

;

Save Embed

;

Guizhou Xinbang Pharmaceutical Co Growth Rank Related Terms

Thank you for viewing the detailed overview of Guizhou Xinbang Pharmaceutical Co's Growth Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Guizhou Xinbang Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Guizhou Xinbang Pharmaceutical Co Ltd (SZSE:002390) » Definitions » Growth Rank

Traded in Other Exchanges

N/A

Address

6th Floor, Kekai 1st Court, Intersection of Aerospace Avenue and Xintian Avenue, Wudang District, Guiyang, CHN

Website

http://www.xinbang.com

Guizhou Xinbang Pharmaceutical Co Ltd is a China-based pharmaceutical company. The company is engaged in providing medical services and pharmaceutical distribution. The scope of business also covers the cultivation of Chinese herbal medicines, production of Chinese herbal medicines and Chinese patent medicines, research and development, production and sales of biological drugs, and other fields.

Executives

An Ji	Director
Gao Wen Lin	Executives
Lu Ya Fang	Executives
Xu Qi	Directors, executives
An Huai Lve	Director
Ma Cheng	Director
Zhang Jie Qing	Directors, executives
Kong Ling Zhong	Directors, executives
Liu Xiao Yang	Executives
Xiao Ya Yun	Executives
Yang Pei	Executives
Zhang Guan Fu	Director
Chen Chuan	Directors, executives
He Wen Jun	Supervisors
Lv Yu Tao	Director

Guizhou Xinbang Pharmaceutical Co Headlines

No Headlines